Activity

Filter

Cancel
Date Panel Item Activity
42 actions
Neuroendocrine cancer pertinent cancer susceptibility v1.4 SDHA Arina Puzriakova Phenotypes for gene: SDHA were changed from Neuroendocrine cancer to Paragangliomas 5, OMIM:614165
Neuroendocrine cancer pertinent cancer susceptibility v1.3 SDHB Arina Puzriakova Phenotypes for gene: SDHB were changed from Neuroendocrine cancer to Paragangliomas 4, OMIM:115310; Pheochromocytoma, OMIM:171300; Paraganglioma and gastric stromal sarcoma, OMIM:606864
Neuroendocrine cancer pertinent cancer susceptibility v1.2 CDKN1B Arina Puzriakova Phenotypes for gene: CDKN1B were changed from Neuroendocrine cancer to Multiple endocrine neoplasia, type IV, OMIM:610755
Neuroendocrine cancer pertinent cancer susceptibility v1.1 MAX Arina Puzriakova Phenotypes for gene: MAX were changed from Neuroendocrine cancer to {Pheochromocytoma, susceptibility to}, OMIM:171300
Neuroendocrine cancer pertinent cancer susceptibility v1.0 Louise Daugherty promoted panel to version 1.0
Neuroendocrine cancer pertinent cancer susceptibility Ellen McDonagh approved panel
Neuroendocrine cancer pertinent cancer susceptibility VHL Ellen McDonagh classified VHL as green
Neuroendocrine cancer pertinent cancer susceptibility VHL Ellen McDonagh commented on VHL
Neuroendocrine cancer pertinent cancer susceptibility TMEM127 Ellen McDonagh classified TMEM127 as green
Neuroendocrine cancer pertinent cancer susceptibility TMEM127 Ellen McDonagh commented on TMEM127
Neuroendocrine cancer pertinent cancer susceptibility SDHD Ellen McDonagh classified SDHD as green
Neuroendocrine cancer pertinent cancer susceptibility SDHD Ellen McDonagh commented on SDHD
Neuroendocrine cancer pertinent cancer susceptibility SDHC Ellen McDonagh classified SDHC as green
Neuroendocrine cancer pertinent cancer susceptibility SDHC Ellen McDonagh commented on SDHC
Neuroendocrine cancer pertinent cancer susceptibility SDHB Ellen McDonagh classified SDHB as green
Neuroendocrine cancer pertinent cancer susceptibility SDHB Ellen McDonagh commented on SDHB
Neuroendocrine cancer pertinent cancer susceptibility SDHAF2 Ellen McDonagh classified SDHAF2 as green
Neuroendocrine cancer pertinent cancer susceptibility SDHAF2 Ellen McDonagh commented on SDHAF2
Neuroendocrine cancer pertinent cancer susceptibility SDHA Ellen McDonagh classified SDHA as green
Neuroendocrine cancer pertinent cancer susceptibility SDHA Ellen McDonagh commented on SDHA
Neuroendocrine cancer pertinent cancer susceptibility RET Ellen McDonagh classified RET as green
Neuroendocrine cancer pertinent cancer susceptibility RET Ellen McDonagh commented on RET
Neuroendocrine cancer pertinent cancer susceptibility MEN1 Ellen McDonagh classified MEN1 as green
Neuroendocrine cancer pertinent cancer susceptibility MEN1 Ellen McDonagh commented on MEN1
Neuroendocrine cancer pertinent cancer susceptibility MAX Ellen McDonagh classified MAX as green
Neuroendocrine cancer pertinent cancer susceptibility MAX Ellen McDonagh commented on MAX
Neuroendocrine cancer pertinent cancer susceptibility FH Ellen McDonagh classified FH as green
Neuroendocrine cancer pertinent cancer susceptibility FH Ellen McDonagh commented on FH
Neuroendocrine cancer pertinent cancer susceptibility CDKN1B Ellen McDonagh commented on CDKN1B
Neuroendocrine cancer pertinent cancer susceptibility CDKN1B Ellen McDonagh classified CDKN1B as green
Neuroendocrine cancer pertinent cancer susceptibility FH Clare Turnbull reviewed FH
Neuroendocrine cancer pertinent cancer susceptibility VHL Clare Turnbull reviewed VHL
Neuroendocrine cancer pertinent cancer susceptibility TMEM127 Clare Turnbull reviewed TMEM127
Neuroendocrine cancer pertinent cancer susceptibility SDHD Clare Turnbull reviewed SDHD
Neuroendocrine cancer pertinent cancer susceptibility SDHC Clare Turnbull reviewed SDHC
Neuroendocrine cancer pertinent cancer susceptibility SDHB Clare Turnbull reviewed SDHB
Neuroendocrine cancer pertinent cancer susceptibility SDHAF2 Clare Turnbull reviewed SDHAF2
Neuroendocrine cancer pertinent cancer susceptibility SDHA Clare Turnbull reviewed SDHA
Neuroendocrine cancer pertinent cancer susceptibility RET Clare Turnbull reviewed RET
Neuroendocrine cancer pertinent cancer susceptibility MEN1 Clare Turnbull reviewed MEN1
Neuroendocrine cancer pertinent cancer susceptibility MAX Clare Turnbull reviewed MAX
Neuroendocrine cancer pertinent cancer susceptibility CDKN1B Clare Turnbull reviewed CDKN1B